Article
Mutation in TET2 in myeloid cancers.
The New England journal of medicine - 28 May 2009
Delhommeau François, Dupont Sabrina, Della Valle Véronique, James Chloé, Trannoy Severine, Massé Aline, Kosmider Olivier, Le Couedic Jean-Pierre, Robert Fabienne, Alberdi Antonio, Lécluse Yann, Plo Isabelle, Dreyfus François J, Marzac Christophe, Casadevall Nicole, Lacombe Catherine, Romana Serge P, Dessen Philippe, Soulier Jean, Viguié Franck, Fontenay Michaela, Vainchenker William, Bernard Olivier A
Abstract excerpt
BACKGROUND: The myelodysplastic syndromes and myeloproliferative disorders are associated with deregulated production of myeloid cells. The mechanisms underlying these disorders are not well defined. METHODS: We conducted a combination of molecular, cytogenetic, comparative-genomic-hybridization, and single-nucleotide-polymorphism analyses to identify a candidate tumor-suppressor gene common to patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
